Revolution Medicines
RVMD
RVMD
135 hedge funds and large institutions have $1.49B invested in Revolution Medicines in 2022 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 42 increasing their positions, 40 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more ownership
Funds ownership: →
5% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 40
21% less capital invested
Capital invested by funds: $1.89B → $1.49B (-$397M)
99% less call options, than puts
Call options by funds: $6K | Put options by funds: $488K
Holders
135
Holding in Top 10
10
Calls
$6K
Puts
$488K
Top Buyers
| 1 | +$58.5M | |
| 2 | +$40.6M | |
| 3 | +$25.8M | |
| 4 |
CG
Column Group
San Francisco,
California
|
+$20.4M |
| 5 |
JPMorgan Chase & Co
New York
|
+$9.98M |
Top Sellers
| 1 | -$54.6M | |
| 2 | -$40.3M | |
| 3 | -$31.3M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$9.57M |
| 5 |
TGI
TRV GP III
Boston,
Massachusetts
|
-$8.18M |